qaialdo
nova laboratories ireland limited - spironolacton - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 og 5.
candesartancilexetil "paranova" 4 mg tabletter
paranova danmark a/s - candesartancilexetil - tabletter - 4 mg
imprida hct
novartis europharm ltd. - amlodipin, valsartan, hydrochlorthiazid - forhøjet blodtryk - angiotensin ii antagonister, plain, angiotensin ii antagonister, kombinationer - behandling af essentiel hypertension som substitution terapi hos voksne patienter, hvis blodtryk er tilstrækkeligt kontrolleret på kombinationen af amlodipin, valsartan og hydrochlorthiazid (hct), taget enten tre single-komponent formuleringer eller som en dual-komponent og en enkelt-komponent formulering.
ramipril/hydrochlorthiazid "ratiopharm" 5+25 mg tabletter
ratiopharm gmbh - hydrochlorthiazid, ramipril - tabletter - 5+25 mg
spiron 100 mg tabletter
orion corporation - spironolacton - tabletter - 100 mg
spiron 25 mg tabletter
orion corporation - spironolacton - tabletter - 25 mg
spiron 50 mg tabletter
orion corporation - spironolacton - tabletter - 50 mg
concerta 18 mg depottabletter
orifarm a/s - methylphenidathydrochlorid - depottabletter - 18 mg